意义不明的α-半乳糖苷酶 A 基因变异:法布里病的细胞划分

IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Journal of Inherited Metabolic Disease Pub Date : 2024-04-15 DOI:10.1002/jimd.12743
Alexandra Klein, Katharina Klug, Maximilian Breyer, Julia Grüner, Vijay Krishna Medala, Peter Nordbeck, Christoph Wanner, Eva Klopocki, Nurcan Üçeyler
{"title":"意义不明的α-半乳糖苷酶 A 基因变异:法布里病的细胞划分","authors":"Alexandra Klein,&nbsp;Katharina Klug,&nbsp;Maximilian Breyer,&nbsp;Julia Grüner,&nbsp;Vijay Krishna Medala,&nbsp;Peter Nordbeck,&nbsp;Christoph Wanner,&nbsp;Eva Klopocki,&nbsp;Nurcan Üçeyler","doi":"10.1002/jimd.12743","DOIUrl":null,"url":null,"abstract":"<p>Fabry disease (FD) is an X-linked multiorgan disorder caused by variants in the alpha-galactosidase A gene (<i>GLA</i>). Depending on the variant, disease phenotypes range from benign to life-threatening. More than 1000 <i>GLA</i> variants are known, but a link between genotype and phenotype in FD has not yet been established for all. p.A143T, p.D313Y, and p.S126G are frequent examples of variants of unknown significance (VUS). We have investigated the potential pathogenicity of these VUS combining clinical data with data obtained in human cellular in vitro systems. We have analyzed four different male subject-derived cell types for alpha-galactosidase A enzyme (GLA) activity and intracellular Gb3 load. Additionally, Gb3 load in skin tissue as well as clinical data were studied for correlates of disease manifestations. A reduction of GLA activity was observed in cells carrying p.A143T compared with controls (<i>p</i> &lt; 0.05). In cells carrying the p.D313Y variant, a reduced GLA activity was found only in endothelial cells (<i>p</i> &lt; 0.01) compared with controls. No pathological changes were observed in cells carrying the p.S126G variant. None of the VUS investigated caused intracellular Gb3 accumulation in any cell type. Our data of aberrant GLA activity in cells of p.A143T hemizygotes and overall normal cellular phenotypes in cells of p.D313Y and p.S126G hemizygotes contribute a basic science perspective to the clinically highly relevant discussion on VUS in <i>GLA</i>.</p>","PeriodicalId":16281,"journal":{"name":"Journal of Inherited Metabolic Disease","volume":"47 4","pages":"805-817"},"PeriodicalIF":4.2000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jimd.12743","citationCount":"0","resultStr":"{\"title\":\"Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry disease\",\"authors\":\"Alexandra Klein,&nbsp;Katharina Klug,&nbsp;Maximilian Breyer,&nbsp;Julia Grüner,&nbsp;Vijay Krishna Medala,&nbsp;Peter Nordbeck,&nbsp;Christoph Wanner,&nbsp;Eva Klopocki,&nbsp;Nurcan Üçeyler\",\"doi\":\"10.1002/jimd.12743\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Fabry disease (FD) is an X-linked multiorgan disorder caused by variants in the alpha-galactosidase A gene (<i>GLA</i>). Depending on the variant, disease phenotypes range from benign to life-threatening. More than 1000 <i>GLA</i> variants are known, but a link between genotype and phenotype in FD has not yet been established for all. p.A143T, p.D313Y, and p.S126G are frequent examples of variants of unknown significance (VUS). We have investigated the potential pathogenicity of these VUS combining clinical data with data obtained in human cellular in vitro systems. We have analyzed four different male subject-derived cell types for alpha-galactosidase A enzyme (GLA) activity and intracellular Gb3 load. Additionally, Gb3 load in skin tissue as well as clinical data were studied for correlates of disease manifestations. A reduction of GLA activity was observed in cells carrying p.A143T compared with controls (<i>p</i> &lt; 0.05). In cells carrying the p.D313Y variant, a reduced GLA activity was found only in endothelial cells (<i>p</i> &lt; 0.01) compared with controls. No pathological changes were observed in cells carrying the p.S126G variant. None of the VUS investigated caused intracellular Gb3 accumulation in any cell type. Our data of aberrant GLA activity in cells of p.A143T hemizygotes and overall normal cellular phenotypes in cells of p.D313Y and p.S126G hemizygotes contribute a basic science perspective to the clinically highly relevant discussion on VUS in <i>GLA</i>.</p>\",\"PeriodicalId\":16281,\"journal\":{\"name\":\"Journal of Inherited Metabolic Disease\",\"volume\":\"47 4\",\"pages\":\"805-817\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jimd.12743\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Inherited Metabolic Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jimd.12743\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inherited Metabolic Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jimd.12743","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

法布里病(FD)是一种由α-半乳糖苷酶A基因(GLA)变异引起的X连锁多器官疾病。根据变异的不同,疾病表型从良性到危及生命不等。p.A143T、p.D313Y 和 p.S126G 是意义不明变异(VUS)的常见例子。我们结合临床数据和在人体细胞体外系统中获得的数据,对这些 VUS 的潜在致病性进行了研究。我们分析了四种不同的男性受试者衍生细胞类型的α-半乳糖苷酶 A 酶(GLA)活性和细胞内 Gb3 负荷。此外,我们还研究了皮肤组织中的 Gb3 负荷以及与疾病表现相关的临床数据。与对照组相比,在携带 p.A143T 的细胞中观察到 GLA 活性降低(p < 0.05)。在携带 p.D313Y 变异的细胞中,与对照组相比,仅在内皮细胞中发现 GLA 活性降低(p < 0.01)。在携带 p.S126G 变异的细胞中没有观察到病理变化。所研究的 VUS 均未在任何细胞类型中引起细胞内 Gb3 的积累。我们的数据表明,p.A143T 杂合子细胞中的 GLA 活性异常,而 p.D313Y 和 p.S126G 杂合子细胞中的细胞表型总体正常,这些数据为临床上与 GLA 高度相关的 VUS 讨论提供了一个基础科学视角。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry disease

Fabry disease (FD) is an X-linked multiorgan disorder caused by variants in the alpha-galactosidase A gene (GLA). Depending on the variant, disease phenotypes range from benign to life-threatening. More than 1000 GLA variants are known, but a link between genotype and phenotype in FD has not yet been established for all. p.A143T, p.D313Y, and p.S126G are frequent examples of variants of unknown significance (VUS). We have investigated the potential pathogenicity of these VUS combining clinical data with data obtained in human cellular in vitro systems. We have analyzed four different male subject-derived cell types for alpha-galactosidase A enzyme (GLA) activity and intracellular Gb3 load. Additionally, Gb3 load in skin tissue as well as clinical data were studied for correlates of disease manifestations. A reduction of GLA activity was observed in cells carrying p.A143T compared with controls (p < 0.05). In cells carrying the p.D313Y variant, a reduced GLA activity was found only in endothelial cells (p < 0.01) compared with controls. No pathological changes were observed in cells carrying the p.S126G variant. None of the VUS investigated caused intracellular Gb3 accumulation in any cell type. Our data of aberrant GLA activity in cells of p.A143T hemizygotes and overall normal cellular phenotypes in cells of p.D313Y and p.S126G hemizygotes contribute a basic science perspective to the clinically highly relevant discussion on VUS in GLA.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Inherited Metabolic Disease
Journal of Inherited Metabolic Disease 医学-内分泌学与代谢
CiteScore
9.50
自引率
7.10%
发文量
117
审稿时长
4-8 weeks
期刊介绍: The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). By enhancing communication between workers in the field throughout the world, the JIMD aims to improve the management and understanding of inherited metabolic disorders. It publishes results of original research and new or important observations pertaining to any aspect of inherited metabolic disease in humans and higher animals. This includes clinical (medical, dental and veterinary), biochemical, genetic (including cytogenetic, molecular and population genetic), experimental (including cell biological), methodological, theoretical, epidemiological, ethical and counselling aspects. The JIMD also reviews important new developments or controversial issues relating to metabolic disorders and publishes reviews and short reports arising from the Society''s annual symposia. A distinction is made between peer-reviewed scientific material that is selected because of its significance for other professionals in the field and non-peer- reviewed material that aims to be important, controversial, interesting or entertaining (“Extras”).
期刊最新文献
Issue Information Potential therapeutic uses of L-citrulline beyond genetic urea cycle disorders Epidemiology and economic burden of Wilson disease in France: A nationwide population-based study. Human glyoxylate metabolism revisited: New insights pointing to multi-organ involvement with implications for siRNA-based therapies in primary hyperoxaluria. My path to citrin deficiency.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1